🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Vicki L. Keedy

Vanderbilt University

ORCID: 0000-0002-7213-7562

Also affiliated with Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

A prospective study evaluating the association of patient-reported outcomes with activity level and sleep patterns in sarcoma survivors.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.12085
Top 100%
0DataRank
Top 100%0 citations

Emma Schremp, Tatsuki Koyama, Lili Sun, Lauren King, Vicki L. Keedy +7 more

Papers

Driven by 9 papers — median percentile 0. Top paper: “Safety, pharmacokinetic, pharmacodynamic and clinical activity of molibresib for the treatment of nuclear protein of the testis carcinoma and other cancers: Results of a Phase I/II open‐label, dose escalation study”.

Safety, pharmacokinetic, pharmacodynamic and clinical activity of molibresib for the treatment of nuclear protein of the testis carcinoma and other cancers: Results of a Phase I/II open‐label, dose escalation study

International Journal of Cancer(2021)10.1002/ijc.33861
N/A
1.9DataRank · unranked
62 citations

Jean‐Yves Blay, Irene García, Johann S. De Bono, Christophe Le Tourneau, Víctor Moreno +25 more

Results from Phase I Extension Study Assessing Pexidartinib Treatment in Six Cohorts with Solid Tumors including TGCT, and Abnormal CSF1 Transcripts in TGCT

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-2007
N/A
0.965DataRank · unranked
32 citations

Arun S. Singh, Stephen P. Anthony, Mike Sterba, Chao Zhang, John H. Healey +19 more

Larotrectinib efficacy and safety in adult patients with tropomyosin receptor kinase fusion sarcomas

Cancer(2023)10.1002/cncr.35036
N/A
0.937DataRank · unranked
25 citations

Lin Shen, David S. Hong, Ray McDermott, Vicki L. Keedy, Michela Casanova +19 more

A multicenter evaluation of treatment patterns and outcomes for Adamantinoma-like Ewing sarcoma.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.e23500
N/A
0DataRank · unranked
1 citations

Daniel Ying Wang, Vicki L. Keedy, Elizabeth J. Davis, Rodney Dixon Dorand

A Retrospective Multi-Institutional Cohort Analysis of Clinical Characteristics and Outcomes in Dedifferentiated Chondrosarcoma

Cancers(2023)10.3390/cancers15092617
N/A
0DataRank · unranked
17 citations

Hilary Dietz, Sheima Farag, Angela C. Hirbe, Michael J. Wagner, Brian A. Van Tine +5 more

A prospective study evaluating the association of patient-reported outcomes with activity level and sleep patterns in sarcoma survivors.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.12085
Top 100%
0DataRank
Top 100%0 citations

Emma Schremp, Tatsuki Koyama, Lili Sun, Lauren King, Vicki L. Keedy +7 more

Desmoid tumor control with liposomal doxorubicin: a dual-center retrospective analysis

Expert Review of Anticancer Therapy(2025)10.1080/14737140.2025.2545551
N/A
0DataRank · unranked
1 citations

Rodney Dixon Dorand, Sean Cohen, Vicki L. Keedy, Scott C. Borinstein, Scott M. Schuetze +3 more

A pilot study of the feasibility and utility of a fitness tracker to correlate activity level with patient reported outcomes (PROs) in sarcoma patients undergoing systemic therapy.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.11559
N/A
0DataRank · unranked
0 citations

Gregory D. Ayers, Deborah Wallace, Elizabeth Kaiser, Vicki L. Keedy, Rajiv Agarwal +1 more

Efficacy of liposomal doxorubicin in patients with intra- and extra-abdominal desmoid fibromatosis.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.11581
N/A
0DataRank · unranked
3 citations

Sean Cohen, Vicki L. Keedy, Scott C. Borinstein, Rashmi Chugh, Elizabeth J. Davis +1 more